BERNS PAUL L

Average Profitability
12.2%
Insider Buys Quantity
1
Insider Buys Sum
$605,634.36
Insider Sells Quantity
11
Insider Sells Sum
$6.08M

Insider Activity of BERNS PAUL L

The largest purchase of all time was on 2016-04-20 and amounted to 234742 shares of Cellectar Biosciences, Inc. for $605,634.

The largest sale of all time was on 2012-03-09 and amounted to 78400 shares of Jazz Pharmaceuticals plc for $3.89M.

Biography of BERNS PAUL L

No biography is available at this moment.

2021-08-05SaleJazz Pharmaceuticals plc
JAZZ
director
1,450
0.0025%
$154.00$223,300-3.95%
2020-11-04SaleJazz Pharmaceuticals plc
JAZZ
director
4,691
0.0081%
$150.42$705,604+3.31%
2020-08-07SaleJazz Pharmaceuticals plc
JAZZ
director
931
0.0017%
$125.87$117,185+29.08%
2019-08-09SaleJazz Pharmaceuticals plc
JAZZ
director
726
0.0013%
$135.65$98,481-9.37%
2018-08-10SaleJazz Pharmaceuticals plc
JAZZ
director
660
0.0011%
$176.61$116,563-21.48%
2017-08-11SaleJazz Pharmaceuticals plc
JAZZ
director
662
0.0011%
$142.37$94,248+4.2%
2016-08-15SaleJazz Pharmaceuticals plc
JAZZ
director
633
0.001%
$136.45$86,373-2.62%
2016-04-20PurchaseCellectar Biosciences, Inc.
CLRB
director
234,742
6.8256%
$2.58$605,634+12.2%
2015-08-10SaleJazz Pharmaceuticals plc
JAZZ
director
1,602
0.0026%
$180.00$288,355-22.09%
2014-08-12SaleJazz Pharmaceuticals plc
JAZZ
director
2,174
0.0036%
$133.15$289,468+30.62%
2013-08-13SaleJazz Pharmaceuticals plc
JAZZ
director
2,140
0.0037%
$81.86$175,180+65.54%
2012-03-09SaleJazz Pharmaceuticals plc
JAZZ
director
78,400
0.1481%
$49.56$3.89M+3.47%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.